KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Chemed (CHE) Revenue (2016 - 2026)

Chemed filings provide 18 years of Revenue readings, the most recent being $657.5 million for Q1 2026.

  • For the quarter ending Q1 2026, Revenue rose 1.63% year-over-year to $657.5 million, compared with a TTM value of $2.5 billion through Mar 2026, up 2.07%, and an annual FY2025 reading of $2.5 billion, up 4.06% over the prior year.
  • Revenue hit $657.5 million in Q1 2026 for Chemed, up from $639.3 million in the prior quarter.
  • The five-year high for Revenue was $657.5 million in Q1 2026, with the low at $526.5 million in Q3 2022.
  • Median Revenue over the past 5 years was $589.2 million (2024), compared with a mean of $589.3 million.
  • The sharpest move saw Revenue fell 2.26% in 2022, then increased 9.79% in 2025.
  • Year by year, Revenue stood at $546.7 million in 2022, then increased by 7.18% to $585.9 million in 2023, then grew by 9.23% to $640.0 million in 2024, then dropped by 0.1% to $639.3 million in 2025, then increased by 2.84% to $657.5 million in 2026.
  • According to Business Quant data, Revenue over the past three periods came in at $657.5 million, $639.3 million, and $624.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.